Estimating Hypothetically Negotiated Royalty Rates After MedImmune, Inc. v Genentech, Inc. et al
$25.00v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
Showing all 2 results

v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008

v15i1: pp. 93-104 David Boyd; Thomas R. Ireland Antitrust 2008
How Economists can help in litigation involving personal injury, death or discrimination: Additional comments and suggestions for analysis
1 × $25.00
Response to Comment on the Albrecht Review of the Three Arguments Used to Justify Including A Risk-Premium in the Discount Factor
1 × $25.00
U.S. supreme court's decision in Business Electronics v. Sharp: A victory for vertical price fixing
2 × $25.00 Subtotal: $100.00